Advertisement
Screener

Tabula Rasa HealthCare, Inc. Research and Development Expense

Tabula Rasa HealthCare, Inc. Research and Development Expense

Tabula Rasa HealthCare, Inc. reported Research and Development Expense of $1.78 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2023-08-08

  • Tabula Rasa HealthCare, Inc. research and development expense for the quarter ending 2023-06-30 was $1.78M, a 45.21% decline year-over-year.
  • Tabula Rasa HealthCare, Inc. research and development expense for the quarter ending 2023-03-31 was $1.28M, a 67.74% decline year-over-year.
  • Tabula Rasa HealthCare, Inc. research and development expense for the quarter ending 2022-12-31 was $3.26M, a 8.51% decline year-over-year.
  • Tabula Rasa HealthCare, Inc. research and development expense for the quarter ending 2022-09-30 was $4.02M, a 8.62% increase year-over-year.
  • Tabula Rasa HealthCare, Inc. research and development expense for fiscal 2022 was $14.48M, a 1.00% decline from fiscal 2021.
  • Tabula Rasa HealthCare, Inc. research and development expense for fiscal 2021 was $14.63M, a 1.41% increase from fiscal 2020.
  • Tabula Rasa HealthCare, Inc. research and development expense for fiscal 2020 was $14.43M, a 33.64% decline from fiscal 2019.
  • Tabula Rasa HealthCare, Inc. research and development expense for fiscal 2019 was $21.74M, a 77.87% increase from fiscal 2018.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2023-06-30$1.78M
10-Q · filed 2023-08-08
$3.06M
10-Q · filed 2023-08-08
$6.31M
derived: sum of 3 quarters · filed 2023-08-08
$10.33M
derived: sum of 4 quarters · filed 2023-08-08
2023-03-31$1.28M
10-Q · filed 2023-05-09
$4.54M
derived: sum of 2 quarters · filed 2023-05-09
$8.55M
derived: sum of 3 quarters · filed 2023-05-09
$11.80M
derived: sum of 4 quarters · filed 2023-08-08
2022-12-31$3.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
$7.28M
derived: sum of 2 quarters · filed 2023-03-10
$10.52M
derived: sum of 3 quarters · filed 2023-08-08
$14.48M
10-K · filed 2023-03-10
2022-09-30$4.02M
10-Q · filed 2022-11-04
$7.26M
derived: sum of 2 quarters · filed 2023-08-08
$11.23M
10-Q · filed 2022-11-04
$14.79M
derived: sum of 4 quarters · filed 2023-08-08
2022-06-30$3.24M
10-Q · filed 2023-08-08
$7.21M
10-Q · filed 2023-08-08
$10.77M
derived: sum of 3 quarters · filed 2023-08-08
$14.47M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$3.96M
10-Q · filed 2023-05-09
$7.53M
derived: sum of 2 quarters · filed 2023-05-09
$11.22M
derived: sum of 3 quarters · filed 2023-05-09
$15.54M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
$7.26M
derived: sum of 2 quarters · filed 2023-03-10
$11.57M
derived: sum of 3 quarters · filed 2023-03-10
$14.63M
10-K · filed 2023-03-10
$19.79M
10-K · filed 2022-02-25
2021-09-30$3.70M
10-Q · filed 2022-11-04
$4.98M
10-Q · filed 2021-11-05
$8.01M
derived: sum of 2 quarters · filed 2022-11-04
$11.07M
10-Q · filed 2022-11-04
$14.89M
10-Q · filed 2021-11-05
$11.74M
derived: sum of 4 quarters · filed 2023-03-10
2021-06-30$4.31M
10-Q · filed 2022-08-05
$5.92M
10-Q · filed 2021-08-06
$7.37M
10-Q · filed 2022-08-05
$9.91M
10-Q · filed 2021-08-06
$8.05M
derived: sum of 3 quarters · filed 2023-03-10
$13.15M
derived: sum of 4 quarters · filed 2023-03-10
2021-03-31$3.06M
10-Q · filed 2022-05-09
$3.99M
10-Q · filed 2021-05-07
$3.73M
derived: sum of 2 quarters · filed 2023-03-10
$8.84M
derived: sum of 3 quarters · filed 2023-03-10
$12.66M
derived: sum of 4 quarters · filed 2023-03-10
2020-12-31$676.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
$5.78M
derived: sum of 2 quarters · filed 2023-03-10
$9.60M
derived: sum of 3 quarters · filed 2023-03-10
$14.43M
10-K · filed 2023-03-10
$18.18M
10-K · filed 2021-02-26
2020-09-30$5.10M
10-Q · filed 2021-11-05
$8.92M
derived: sum of 2 quarters · filed 2021-11-05
$13.75M
10-Q · filed 2021-11-05
$18.84M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$3.82M
10-Q · filed 2021-08-06
$8.65M
10-Q · filed 2021-08-06
$13.74M
derived: sum of 3 quarters · filed 2022-02-25
$19.64M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$4.83M
10-Q · filed 2021-05-07
$9.92M
derived: sum of 2 quarters · filed 2022-02-25
$15.82M
derived: sum of 3 quarters · filed 2022-02-25
$21.02M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$5.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$10.99M
derived: sum of 2 quarters · filed 2022-02-25
$16.19M
derived: sum of 3 quarters · filed 2022-02-25
$21.74M
10-K · filed 2022-02-25
2019-09-30$5.90M
10-Q · filed 2020-11-06
$11.10M
derived: sum of 2 quarters · filed 2020-11-06
$16.65M
10-Q · filed 2020-11-06
$20.36M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$5.20M
10-Q · filed 2020-08-06
$10.75M
10-Q · filed 2020-08-06
$14.45M
derived: sum of 3 quarters · filed 2021-02-26
$17.83M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$5.55M
10-Q · filed 2020-05-08
$9.26M
derived: sum of 2 quarters · filed 2021-02-26
$12.64M
derived: sum of 3 quarters · filed 2021-02-26
$15.56M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$3.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$7.09M
derived: sum of 2 quarters · filed 2021-02-26
$10.01M
derived: sum of 3 quarters · filed 2021-02-26
$12.22M
10-K · filed 2021-02-26
2018-09-30$3.38M
10-Q · filed 2019-11-08
$6.30M
derived: sum of 2 quarters · filed 2019-11-08
$8.52M
10-Q · filed 2019-11-08
$10.11M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$2.92M
10-Q · filed 2019-08-09
$5.13M
10-Q · filed 2019-08-09
$6.73M
derived: sum of 3 quarters · filed 2020-03-02
$8.25M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$2.21M
10-Q · filed 2019-05-10
$3.80M
derived: sum of 2 quarters · filed 2020-03-02
$5.33M
derived: sum of 3 quarters · filed 2020-03-02
$6.62M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$1.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$3.12M
derived: sum of 2 quarters · filed 2020-03-02
$4.41M
derived: sum of 3 quarters · filed 2020-03-02
$5.63M
10-K · filed 2020-03-02
2017-09-30$1.53M
10-Q · filed 2018-11-08
$2.82M
derived: sum of 2 quarters · filed 2018-11-08
$4.04M
10-Q · filed 2018-11-08
$4.97M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$1.29M
10-Q · filed 2018-08-08
$2.51M
10-Q · filed 2018-08-08
$3.44M
derived: sum of 3 quarters · filed 2019-03-01
$4.47M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$1.22M
10-Q · filed 2018-05-09
$2.15M
derived: sum of 2 quarters · filed 2019-03-01
$3.18M
derived: sum of 3 quarters · filed 2019-03-01
$4.14M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$933.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$1.96M
derived: sum of 2 quarters · filed 2019-03-01
$2.92M
derived: sum of 3 quarters · filed 2019-03-01
$3.81M
10-K · filed 2019-03-01
2016-09-30$1.03M
10-Q · filed 2017-11-09
$1.99M
derived: sum of 2 quarters · filed 2017-11-09
$2.88M
10-Q · filed 2017-11-09
$3.88M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$961.00K
10-Q · filed 2017-08-08
$1.85M
10-Q · filed 2017-08-08
$2.85M
derived: sum of 3 quarters · filed 2018-03-14
$3.54M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$889.00K
10-Q · filed 2017-05-02
$1.89M
derived: sum of 2 quarters · filed 2018-03-14
$2.58M
derived: sum of 3 quarters · filed 2018-03-14
2015-12-31$998.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$1.69M
derived: sum of 2 quarters · filed 2018-03-14
$2.88M
10-K · filed 2018-03-14
2015-09-30$693.00K
10-Q · filed 2016-11-10
$1.88M
10-Q · filed 2016-11-10
2014-12-31$1.66M
10-K · filed 2017-03-14